Insulet (PODD) Appoints Mike Panos as Chief Commercial Officer

Insulet Corporation (NASDAQ:PODD) is 1 of the 8 Most Oversold Strong Buy-Rated Stocks to Invest In.

On March 30, 2026, Insulet Corporation (NASDAQ:PODD) announced the assignment of Mike Panos arsenic Executive Vice President and Chief Commercial Officer, effectual immediately. Mike Panos volition pb the company’s planetary commercialized enactment and study to President and Chief Executive Officer Ashley McEvoy, portion besides joining the Executive Leadership Team. Mike Panos brings 30 years of commercialized enactment acquisition successful aesculapian technology, astir precocious serving arsenic Leader, Sales Excellence astatine Stryker Corporation.

On March 13, 2026, Truist said shares of Insulet were trading little pursuing an 8-K disclosure of a Voluntary Device Correction for definite Omnipod 5 lots. Truist noted the contented could service arsenic a antagonistic header amid expanding competition, but said the interaction should beryllium manageable, citing 18 reported superior adverse events with nary deaths and nary alteration to guidance. Truist added that remediation costs volition beryllium excluded from non-GAAP results and maintained a Buy standing with a terms target, portion noting the banal absorption appears worse than the apt fiscal oregon marketplace stock impact.

Cherries/Shutterstock.com

Earlier successful March, Insulet presented caller objective information supporting the improvement of its afloat closed-loop automated insulin transportation strategy for benignant 2 diabetes astatine the ATTD league successful Barcelona. The EVOLUTION 2C feasibility survey included 24 participants and showed clip successful scope accrued to 68%, a 24% betterment implicit modular injection therapy, with clip beneath scope astatine 0.14%. The survey reported nary terrible hypoglycemia oregon diabetic ketoacidosis events, with improved glycemic outcomes observed crossed a divers subordinate group.

Insulet Corporation (NASDAQ:PODD) develops, manufactures, and sells insulin transportation systems for radical with insulin-dependent diabetes.

While we admit the imaginable of PODD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.